Samsung-WellDoc Partnership Expands with Direct-to-Consumer Diabetes Management App
Continuing with our theme today of signs of the maturing of the digital health market: Samsung and WellDoc have announced a partnership to offer a new app to patients managing chronic diabetes.
BlueStarC will be available directly to consumers under Samsung’s newly launched mobile health app Samsung Health (formerly known as S Health). The diabetes management app is the third incarnation of WellDoc’s mobile tool that analyzes patient-entered diabetes data to compare past trends, offer near-real-time feedback and create personalized condition management plans and progress reports users can share with family and healthcare professionals.
The new app, which is the most distinctly lifestyle-focused of all three BlueStar apps, marks WellDoc’s biggest step into the consumer tech space to date. The company also offers a prescription-only version of the app called BlueStarRX, and in January received FDA clearance for the non-prescription version. That move allowed WellDoc to offer the product through more channels, and the BlueStarC version expands opportunities even further, as it falls under the FDA’s category of enforced discretion and is considered low-risk. All versions analyze diabetes data entered by the patient and compare past trends to create personalized management plans, but the non-prescription and BlueStar C versions do not feature the insulin calculator of BlueStarRX.
“This is something we’ve been working towards for awhile,” WellDoc CEO Kevin McRaith told MobiHealthNews. “The key was to make the user experience as simplified and valuable as possible. By integrating with Samsung Health, that really enables us to scale, and we are really excited for the partnership.”
All signs suggest the partnership will be mutually beneficial, and it’s likely we will see the alliance expand in the future.
As an investor, partner and distribution channel provider for WellDoc, Samsung offers a lot to the digital health company. But it’s also a significant move for Samsung, which is increasingly taking its entrée into healthcare more seriously.
“Our enhanced partnership with WellDoc gives us an opportunity to serve global consumers, who we believe are ready to embrace the combined health innovations that our companies plan to offer,” Suntae Jung, vice president of R&D for Samsung’s Mobile Communications team, said in a statement.
“Within Samsung and WellDoc, we’re exploring all the ways we can create that user experience to get the right value, however each user wants to connect with the platform,” McRaith said.
This move is one of many showing Samsung is continuing to pursue aggressively pursue a presence in the digital health space–including a February announcement of a collaboration with telemedicine provider American Well, the terms of which have not yet been disclosed.